# FDA Inspection 1089921 - Michael R Sperling, M.D. - May 01, 2019

Source: https://www.keypedia.com/records/fda_inspections/michael-r-sperling-md/872711c8-899b-4c95-9da4-579a60ccfc53
Source feed: FDA_Inspections

> FDA Inspection 1089921 for Michael R Sperling, M.D. on May 01, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1089921
- Company Name: Michael R Sperling, M.D.
- Inspection Date: 2019-05-01
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1177951 - 2022-07-20](https://www.keypedia.com/records/fda_inspections/michael-r-sperling-md/66a265ef-9b00-46a9-943a-5e84c4068980)
- [FDA Inspection 924671 - 2015-05-01](https://www.keypedia.com/records/fda_inspections/michael-r-sperling-md/8ee4a5f1-2e90-4c7f-8f46-a6023274c16f)

Company: https://www.keypedia.com/companies/michael-r-sperling-md/1547d2b7-73c2-443c-9940-89fd5f8e9ce6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c